Covance is building a Center of Excellence (CoE) for Rare Disease,Orphan Drugs and Pediatrics. The CoE is therapeutic area agnostic and contains a diversity of experience and expertise as it pertains to rare disease and pediatric development. Its unique combination of scientific, operational commercial support is based on a centralized structure that seamlessly integrates across therapeutic areas and LabCorp/Covance business units. The CoE will operate in an agile, entrepreneurial manner in driving business awards across emerging biotechs, mature biotechs, mid-size and large pharmaceutical companies
The Director or Senior Director is an experienced leader within the Rare Disease and Orphan Drugs Center of Excellence, and is expected to leverage that experience to aid a team to grow a portfolio of innovative and profitable business, and/or oversee the design of effective and differentiated strategies for operational delivery with clients and internal experts and/or oversee the portfolio of clinical studies being conducted in a therapeutic area within the CDCS, Phase II-IV business. As such the Senior Director is expected to establish and grow client relationships, be seen as an industry leader, be an effective line manager, and engage as a leader and subject matter expert in relevant process improvement and change management activities.